|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/0781 | |
| C12N 5/10 | |||
| C07K 16/00 | |||
| C12P 21/08 |
| (11) | Number of the document | 2540820 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12175198.6 |
| Date of filing the European patent application | 2006-12-08 | |
| (97) | Date of publication of the European application | 2013-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-10 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 06076211 | 2006-06-12 | EP | |
| PCT/NL2005/0008 | 2005-12-09 | WO |
| (72) |
Spits, Hergen, US
Scheeren, Ferenc Alexander, NL
Beaumont, Tim, NL
Diehl, Sean Andrew, NL
|
| (73) |
Academisch Medisch Centrum bij de Universiteit van Amsterdam,
Meibergdreef 9, 1105 AZ Amsterdam,
NL
AIMM Therapeutics B.V., Meibergdreef 59, 1105 BA Amsterdam Zuidoost, NL |
| (54) | MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS |
| MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS |